Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Debt to Equity (2022 - 2025)

Historic Debt to Equity for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $0.32.

  • Orchestra BioMed Holdings' Debt to Equity changed N/A to $0.32 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.32, marking a year-over-year change of. This contributed to the annual value of $0.43 for FY2024, which is N/A changed from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Debt to Equity stood at $0.32 for Q3 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Debt to Equity ranged from a high of $48.76 in Q2 2025 and a low of $0.1 during Q1 2023
  • Over the past 4 years, Orchestra BioMed Holdings' median Debt to Equity value was $0.27 (recorded in 2022), while the average stood at $6.36.